Charles A Rowland Jr is of Orchard Therapeutics plc. Currently has a direct ownership of 0 shares of ORTX, which is worth approximately $0. The most recent transaction as insider was on Jan 24, 2024, when has been sold 12,294 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
n/a 12M change
Total Value Held $0

Charles A Rowland Jr Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 24 2024
SELL
Sale (or disposition) back to the issuer
-
12,294 Reduced 100.0%
0 Ordinary Shares

Also insider at

BPMC
Blueprint Medicines Corp Healthcare
GBIO
Generation Bio Co. Healthcare
VKTX
Viking Therapeutics, Inc. Healthcare
NBRV
Nabriva Therapeutics plc Healthcare
CAR

Charles A Rowland Jr

Fort Washington, PA

Track Institutional and Insider Activities on ORTX

Follow Orchard Therapeutics plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ORTX shares.

Notify only if

Insider Trading

Get notified when an Orchard Therapeutics PLC insider buys or sells ORTX shares.

Notify only if

News

Receive news related to Orchard Therapeutics plc

Track Activities on ORTX